Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients
Status:
Recruiting
Trial end date:
2021-11-15
Target enrollment:
Participant gender:
Summary
In current analysis moderate to severely ill Covid-19 infected patients will be nebulized
with nitroglycerin, and they will be compared with the standard nebulization